Strong
partnerships and licensing agreements with leading scientists, academic centers
of excellence, innovative biotech companies and high quality manufacturers are recognized
as key to RESprotects development and success. The company has worked
diligently to create successful and productive relationships.
Current
Partnerships
RESprotect
has strong scientific co-operations with the Universities of Dresden, Wien and
Leipzig.
Fraunhofer Institut für Toxikologie und Experimentelle Medizin (ITEM), Hannover/Germany
Fraunhofer-Institut für Zelltherapie und Immunologie (IZI), Leipzig/Germany
Institut für Tumorbiologie-Krebsforschung, Universität Wien/Austria
Biotec/Department of Computing, Technical University Dresden/Germany
RESprotect partnered with
Kwang Dong Pharmaceuticals, Inc., Seoul, South Korea, when out-
licensed the RP101 rights for South Korea.